Appeal No. 2006-2587 Page 7 Application No. 09/879,710 administered to human beings in doses from 200 mg to 3 g per day, preferably of 800 mg per day.” According to appellants’ specification (page 5), the therapeutically effective amount called for in appellants’ claimed invention “could range from 100 mg to 10 grams daily. . . .” Thus, the dosage range set forth in Joullié appears to fall within appellants’ disclosed therapeutic range. Accordingly, prior to any further action on the merits, we encourage the examiner to take a step back and reconsider whether Joullié alone, or in combination with any other available prior art, teaches a composition within the scope of appellants’ claimed invention. REVERSED ) Donald E. Adams ) Administrative Patent Judge ) ) ) BOARD OF PATENT ) Lora M. Green ) APPEALS AND Administrative Patent Judge ) ) INTERFERENCES ) ) Richard M. Lebovitz ) Administrative Patent Judge ) DEA/lbgPage: Previous 1 2 3 4 5 6 7 8 NextLast modified: November 3, 2007